Search images on Google Product Monograph
Active Ingredients:
- meningococcal polysaccharide-diphtheria toxoid conjugate, group a, 4.0 MCG/0.5 ML
- meningococcal polysaccharide-diphtheria toxoid conjugate, group c, 4.0 MCG/0.5 ML
- meningococcal polysaccharide-diphtheria toxoid conjugate, group y, 4.0 MCG/0.5 ML
- meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135, 4.0 MCG/0.5 ML
DIN: 02279924
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAMUSCULAR
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
ATC:
- J07 - VACCINES (ATC, WHO, Wiki)
- J07A - BACTERIAL VACCINES (ATC, WHO)
- J07AH - Meningococcal vaccines (ATC, WHO)
- J07AH08 - MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED (WHO)
Reference brand drug:
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1 DOSE VIAL/ 1DOSE SYRINGE
External Links for Menactra:
Search on Google
- Menactra side effects
- Menactra dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group a side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group a dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group c side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group c dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group y side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group y dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 dosage